Bloomer J R
Yale J Biol Med. 1979 Jan-Feb;52(1):39-48.
Protoporphyria is an inherited disorder in man characterized by the overproduction of protoporphyrin, a compound that is excreted by the liver. Hepatobiliary disease may occur in protoporphyria, and several cases have been reported in which death was due to liver disease. Based on the histological evaluation of liver biopsy specimens from 18 patients, 6 of whom died with cirrhosis and liver failure, we speculate that liver disease in this condition is caused by protoporphyrin deposits in hepatobiliary structures. These deposits are composed of crystals and have a characteristic birefringence when examined by polarization microscopy.One patient with early liver damage was given cholestyramine and vitamin E in an attempt to reduce the amount of protoporphyrin which the liver excreted daily. Liver function tests returned to normal, and red cell and plasma protoporphyrin levels decreased. A repeat liver biopsy after one year of therapy showed healing, with decrease of the protoporphyrin deposits.Liver disease in protoporphyria may be treated by directing therapy toward the metabolic abnormality.
原卟啉病是一种人类遗传性疾病,其特征是原卟啉产生过多,原卟啉是一种由肝脏排泄的化合物。原卟啉病可能会引发肝胆疾病,已有数例报告称死亡是由肝脏疾病所致。基于对18例患者肝脏活检标本的组织学评估,其中6例死于肝硬化和肝衰竭,我们推测这种情况下的肝脏疾病是由原卟啉在肝胆结构中的沉积引起的。这些沉积物由晶体组成,在偏振显微镜检查时具有特征性双折射。一名早期肝损伤患者接受了消胆胺和维生素E治疗,以试图减少肝脏每日排泄的原卟啉量。肝功能测试恢复正常,红细胞和血浆原卟啉水平下降。治疗一年后的重复肝脏活检显示病变愈合,原卟啉沉积物减少。原卟啉病中的肝脏疾病可通过针对代谢异常进行治疗。